Oscar Health (NYSE:OSCR) Reaches New 1-Year High – Should You Buy?

Oscar Health, Inc. (NYSE:OSCR)’s share price reached a new 52-week high during trading on Wednesday. The company traded as high as $36.16 and last traded at $33.3370, with a volume of 2,392,551 shares traded. The stock had previously closed at $32.41.

Key Headlines Impacting Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Oscar reported Q3 adjusted earnings of $0.49 per share, versus expectations for a loss, and revenue of $5.14 billion, above the $4.69 billion consensus and up 72.1% year over year. The company also recorded a $167.3 million profit, while membership rose 27.2% to 2.69 million and its medical loss ratio improved to 84%. Oscar Health Q3 2026: A Surprise Profit and Its Third Guidance Raise
• Positive Sentiment: Management raised its 2026 revenue outlook for the third time, to $19 billion–$19.3 billion, above FactSet’s $18.64 billion estimate. The higher forecast signals stronger expected sales than analysts had anticipated. Oscar Health 2026 Revenue Outlook
• Positive Sentiment: Zacks added OSCR to its Rank #1 (Strong Buy) growth-stocks list, adding a favorable analyst-screening signal. Best Growth Stocks to Buy for November 6th
• Neutral Sentiment: Despite the earnings beat and stronger outlook, one report said Oscar shares slipped as other healthcare stocks rose. That points to a mixed immediate reaction, rather than a clear deterioration in the company’s reported results. Oscar slips as LifeStance, HCA climb on earnings, payment hike

Analysts Set New Price Targets

Several research firms recently weighed in on OSCR. Wells Fargo & Company raised their price objective on Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research note on Thursday, August 13th. Piper Sandler reissued an “overweight” rating and set a $48.00 target price on shares of Oscar Health in a research note on Thursday, September 17th. The Goldman Sachs Group reissued a “neutral” rating and issued a $34.00 target price on shares of Oscar Health in a report on Thursday, September 17th. UBS Group increased their target price on shares of Oscar Health from $26.00 to $36.00 and gave the stock a “neutral” rating in a report on Monday, October 12th. Finally, Raymond James Financial raised their price target on shares of Oscar Health from $34.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $34.90.

Oscar Health Price Performance

The company has a 50 day moving average price of $31.80 and a 200-day moving average price of $23.89. The company has a market cap of $10.23 billion, a price-to-earnings ratio of 23.68, a P/E/G ratio of 0.39 and a beta of 2.56. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 5th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of ($0.14) by $0.63. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $4.69 billion. During the same period last year, the company earned ($0.53) EPS. The firm’s revenue was up 72.1% compared to the same quarter last year. As a group, equities research analysts predict that Oscar Health, Inc. will post 1.83 EPS for the current fiscal year.

Insider Activity at Oscar Health

In other news, insider Adam Mcananey sold 9,092 shares of Oscar Health stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $285,943.40. Following the transaction, the insider owned 209,004 shares in the company, valued at approximately $6,573,175.80. The trade was a 4.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Vanessa Wittman sold 25,000 shares of the business’s stock in a transaction on Friday, September 18th. The stock was sold at an average price of $32.24, for a total transaction of $806,000.00. Following the completion of the sale, the director directly owned 112,121 shares in the company, valued at approximately $3,614,781.04. This represents a 18.23% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 874,451 shares of company stock valued at $26,761,671 in the last quarter. Insiders own 22.64% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Several institutional investors and hedge funds have recently made changes to their positions in OSCR. Dimensional Fund Advisors LP boosted its position in shares of Oscar Health by 22.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company’s stock valued at $48,078,000 after purchasing an additional 759,837 shares in the last quarter. Bank of America Corp DE grew its stake in Oscar Health by 205.1% during the first quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after purchasing an additional 1,922,732 shares during the period. Assenagon Asset Management S.A. grew its stake in Oscar Health by 107.5% during the third quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company’s stock worth $79,867,000 after purchasing an additional 1,341,716 shares during the period. Halter Ferguson Financial Inc. increased its holdings in Oscar Health by 93.3% in the third quarter. Halter Ferguson Financial Inc. now owns 1,211,825 shares of the company’s stock worth $37,373,000 after purchasing an additional 584,818 shares in the last quarter. Finally, Wedge Capital Management L L P NC bought a new stake in Oscar Health in the second quarter worth approximately $32,855,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.